Tomato recall across 14 states over Salmonella concerns: Full list of affected products
Salmonella is one of the most common causes of fatal foodborne illness in the United States, according to the U.S. Centers for Disease Control and Prevention (CDC). It can result in a range of symptoms. Some infected people will have no signs, whereas others will develop diarrhea, fever, and stomach pain. Most people will recover without treatment, but the bacteria can lead to potentially deadly outcomes, especially in high-risk groups, such as children under 5 and the elderly.
Recall Date: May 2, 2025
Distribution Dates: April 23–28, 2025
States Affected: Georgia, North Carolina, South Carolina
Product Details:
5×6 25lb H&C Farms label
6×6 25lb H&C Farms label
Combo 25lb
4×4 2-layer
4×5 2-layer
60ct 2-layer
60ct 18lb loose
XL 18lb loose
3ct trays (UPC: 0 33383 65504 8)
Lot Codes: R4467, R4470
What you should do: If you purchased any of the above products, do not consume them. Return them to the point of purchase for a full refund or discard them. For more details call Jason Breland at 843-866-7707 or 843-599-5154.
Recall Date: May 3, 2025
States Affected: Illinois, Indiana, Kentucky, Michigan, Missouri, Mississippi, New York, Ohio, Pennsylvania, Tennessee, Wisconsin
Product Details:
4 Count Vine Ripe Tomatoes in 20 oz plastic clamshells
UPC: 7 96553 20062 1
Lot Numbers: RM250424 15250B, RM250427 15250B
What you should do: Consumers who bought these tomatoes should not consume them. Instead, return the product to the store for a full refund or dispose of it. For more details, you can contact Ray & Mascari Inc by calling 317-637-0234.
Related: 180,000 Safety 1st car seats recalled over choking hazard—what parents need to know
Salmonella is a type of bacteria that can cause severe foodborne illness. According to the Mayo Clinic, the most common symptoms include:
Diarrhea (which may be bloody)
Fever
Nausea
Vomiting
Abdominal pain
In some cases, Salmonella infection can lead to more serious complications, such as:
Arterial infections
Endocarditis (inflammation of the heart lining)
Arthritis
Certain groups, including young children under 5, the elderly, and people with weakened immune systems, are at a higher risk for severe illness or complications.
How to Prevent Salmonella Infections
As per PIRG, about 14% of all food recalls in the U.S. last year were due to possible salmonella contamination.To reduce the risk of Salmonella infections, follow these simple steps:
Wash and sanitize all surfaces that have come into contact with potentially contaminated food.
Wash your hands thoroughly with soap and warm water after handling potentially contaminated food or sanitizing surfaces.
Avoid eating high-risk foods such as raw sprouts, especially if you are immunocompromised.
Prevent cross-contamination with pet food, ensuring that surfaces and utensils used with pet food are sanitized.
By taking these precautions, you can help protect yourself and your loved ones from Salmonella and other foodborne illnesses.
As of now, no illnesses have been reported in connection with either of the recalls. However, due to the serious nature of Salmonella contamination, consumers are urged to follow the recall instructions carefully.
If you have purchased any of the recalled tomatoes, follow these steps:
Do Not Consume: Do not eat the affected tomatoes.
Return or Discard: You can return the recalled products to the store where you purchased them for a full refund. If returning is not an option, discard the tomatoes safely.
Monitor Symptoms: If you experience symptoms of Salmonella infection (e.g., diarrhea, fever, abdominal pain), seek medical advice immediately.
For any questions or further information regarding the recall, consumers can contact the relevant companies using the contact details provided:
Williams Farms Repack LLC:
Phone: 843-866-7707 or 843-599-5154
Business Hours: Monday–Friday, 8:00 am–5:00 pm EST
Ray & Mascari Inc.:
Phone: 1-317-637-0234
Business Hours: Monday–Saturday, 6:00 am–5:00 pm EST
The tomatoes were sold in various sizes and packaging, and the following details apply to all affected products:
Lot Codes: The affected products carry the lot codes R4467 and R4470.
States Affected: The tomatoes were distributed across the South, Midwest, and parts of New York and Pennsylvania.
While no illnesses have been reported yet, consumers in the affected states are urged to dispose of or return the recalled tomatoes to ensure their safety. Salmonella is a serious health risk, and the FDA is closely monitoring the situation to prevent any further risks to public health. For more information, visit the FDA's website or contact the companies involved.
Related: Target recalls baby food over lead concerns—here's what parents should do
Source:
Range of symptoms. CDC. 2025. 'Foodborne Illness Source Estimates.'
Tomato recall. FDA. 2025. 'Williams Farms Repack LLC Recalls Tomatoes Due to Possible Salmonella Contamination.'
Salmonella symptoms. Mayo Clinic. 2025. 'Salmonella infection.'
Food recalls due to Salmonella. PIRG. 2025. 'Food for Thought 2025.'

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
11 hours ago
- Business Wire
Amber Specialty Pharmacy Begins Dispensing Newly Approved BRINSUPRI™ (brensocatib) for Non-Cystic Fibrosisbronchiectasis (NCFB)
OMAHA, Neb.--(BUSINESS WIRE)--Amber Specialty Pharmacy, a pioneer in specialty pharmacy for more than 25 years, today announced it is now dispensing BRINSUPRI™ (brensocatib) following the medication's U.S. Food and Drug Administration (FDA) approval as the first treatment specifically indicated to reduce pulmonary exacerbations in adults and adolescents with non-cystic fibrosis bronchiectasis, a chronic neutrophil-mediated airway disease. 'Our nationally recognized clinical program is ready to ensure rapid access, personalized counseling, and comprehensive reimbursement support for every patient who needs it,' said Kristin Williams, president of Amber Specialty Pharmacy. Amber Specialty Pharmacy streamlines the treatment process for both patients and referring providers by offering the following support services: Nationwide dispensing through its URAC and ACHC-accredited network 24/7 clinical support and adherence counseling from specialty-licensed pharmacists End-to-end benefits investigation, prior authorization and financial assistance coordination Healthcare providers can initiate BRINSUPRI referrals by calling (888) 370-1724 or visiting to download electronic referral forms. About Amber Specialty Pharmacy Amber Specialty Pharmacy is a pioneer in the specialty pharmacy industry, with more than 25 years of experience in providing specialized care for patients with chronic and complex medical conditions. With a focus on personalized support and quality clinical care, Amber Specialty Pharmacy serves patients across the United States. The pharmacy is accredited by both the Utilization Review Accreditation Commission (URAC) and the Accreditation Commission for Health Care (ACHC). Amber Specialty Pharmacy is headquartered in Omaha, Nebraska. To learn more, visit


UPI
18 hours ago
- UPI
First drug to treat bronchiectasis lung condition approved by FDA
The U.S. Food and Drug Administration has approved Insmed's daily bronchiectasis pill, brensocatib, which will be sold under the brand name Brinsupri. File Photo by John Angelillo/UPI | License Photo For the first time, people with bronchiectasis will have a treatment option. The U.S. Food and Drug Administration has approved Insmed's daily pill brensocatib, which will be sold under the brand name Brinsupri. The drug is designed to treat non-cystic fibrosis bronchiectasis, a chronic condition that damages the lungs and makes it harder to clear mucus, the company said in a statement. The approval comes after the medication succeeded in one of last year's most closely watched Phase 3 clinical trials. The company says Brinsupri could become a blockbuster, estimating peak sales at $5 billion a year, STAT News reported. "The FDA approval of the first-ever treatment for non-cystic fibrosis bronchiectasis is a historic milestone for patients and for Insmed," the company's chief medical officer, Dr. Martina Flammer, said in a statement. The American Lung Association estimates that bronchiectasis affects between 350,000 and 500,000 adults in the United States. It happens when the airways in the lungs become widened, thickened and scarred - often after an infection or other damage. This makes it difficult to clear mucus, allowing germs and particles to build up and cause repeated lung infections. Brinsupri works by blocking an enzyme called DPP1. Insmed bought the drug from AstraZeneca for $30 million and is also testing it for other conditions, such as chronic rhinosinusitis, STAT News reported. The company plans to sell the drug in the U.S. at an annual list price of $88,000. It has also filed for approval in Europe and the United Kingdom, and it plans to do so in Japan. "For the first time, we have a treatment that directly targets neutrophilic inflammation and addresses a root cause of bronchiectasis exacerbations. Based on the strength of the data and the impact we've seen in patients, I believe this could become the new standard in non-cystic fibrosis bronchiectasis care." Dr. Doreen Addrizzo-Harris, a pulmonary and critical care physician and director of the NYU Langone Health Bronchiectasis and NTM Program in New York City, said in a news release. More information The American Lung Association has more about bronchiectasis. Copyright © 2025 HealthDay. All rights reserved.


Newsweek
2 days ago
- Newsweek
Chocolate Recall Sparks Nationwide Warning to Customers
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Neuhaus Chocolates NV is recalling their Belgian Chocolate Moments Smurfs 'Popping Milk Chocolates with Cookies because the product contains wheat which was not declared on the packaging. Newsweek reached out to the company via email Monday for comment. Why It Matters Numerous recalls have been initiated this year due to the potential for damaged products, foodborne illness, contamination and undeclared food allergens. Millions of Americans experience food sensitivities or allergies every year. According to the U.S. Food and Drug Administration (FDA), the nine "major" food allergens in the U.S. are eggs, milk, fish, wheat, soybeans, Crustacean shellfish, sesame, tree nuts and peanuts. People with a wheat allergy could experience a "serious or life-threatening allergic reaction if they consume these products," the FDA warns. What To Know Neuhaus Chocolate can be seen related to a recall in August 2025. (Photo from the U.S. Food and Drug Administration) Neuhaus Chocolate can be seen related to a recall in August 2025. (Photo from the U.S. Food and Drug Administration) In the alert, the FDA says the recalled chocolates were distributed from July 21, 2025, until August 4, 2025, by Neuhaus stores in Virginia, New York, Pennsylvania, Maryland, Washington, D.C. and via their online store. The impacted batch numbers are 80108690 and 80108763 with a best use before date of January 13, 2026, the FDA alert says. There have been no reports of illnesses related to this recall and 150 units of the impacted products were sold, the FDA says. What People Are Saying The FDA in their alert in part: "The action was initiated after it was discovered during an internal check that product containing wheat was distributed in packaging that did not reveal the presence of wheat. Subsequent investigation indicates the problem was caused by an exceptional combination of circumstances in which the ERP (Enterprise Resource Planning) did not include the allergen on the packaging." In an email to Newsweek in January, the FDA said: "Most recalls in the U.S. are carried out voluntarily by the product manufacturer and when a company issues a public warning, typically via news release, to inform the public of a voluntary product recall; the FDA shares that release on our website as a public service. "The FDA's role during a voluntary, firm-initiated, recall is to review the recall strategy, evaluate the health hazard presented by the product, monitor the recall, and as appropriate alert the public and other companies in the supply chain about the recall. "The FDA provides public access to information on recalls by posting a listing of recalls according to their classification in the FDA Enforcement Report, including the specific action taken by the recalling company. The FDA Enforcement Report is designed to provide a public listing of products in the marketplace that are being recalled." Additional information on recalls can be found via the FDA's Recalls, Market Withdrawals, & Safety Alerts. What Happens Next Customers who have purchased the recalled product who have a wheat allergy are asked to return it to the original place of purchase and not to consume it, the FDA says. People with additional questions may contact the company via phone at +32 2 568 23 00 from 8 a.m. to 5 p.m. Central European Summer Time on weekdays or via email at customercare@